Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.91
+0.28 (3.24%)
Jan 29, 2026, 3:26 PM EST - Market open
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $501.61 million as of January 29, 2026. Its market cap has increased by 16.60% in one year.
Market Cap
501.61M
Enterprise Value
353.56M
1-Year Change
16.60%
Ranking
Category
Stock Price
$8.91
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $501.61M, an increase of 264.01%. That is a compound annual growth rate of 12.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 485.80M | -3.69% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 530.16M |
| Prothena Corporation | 523.77M |
| Alto Neuroscience | 522.23M |
| Ocugen | 521.34M |
| Contineum Therapeutics | 514.70M |
| Solid Biosciences | 511.87M |
| Verastem | 501.68M |
| Niagen Bioscience | 499.76M |